Sarclisa

Active Ingredient(s): Isatuximab-irfc
FDA Approved: * March 2, 2020
Pharm Company: * SANOFI AVENTIS US
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sarclisa Overview

Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma.[4][3] The most common side effects include neutropenia (low levels of neutrophils, a type of white blood cell), infusion reactions, pneumonia (infection of the lungs), upper respiratory tract infection (such as nose and throat infections), diarrhoea and bronchitis (inflammation of the airways in the lungs).[3] Isatuxim...

Read more Sarclisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Isatuximab

Recent Sarclisa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Isatuximab-irfc
  • Injection: 100mg/5ml (20mg/ml), 500mg/25ml (20mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sarclisa: (2 results)

Sorted by National Drug Code
  • 0024-0654 Sarclisa 100 mg/5ml Intravenous Injection, Solution, Concentrate by Sanof-aventis U.S. LLC
  • 0024-0656 Sarclisa 500 mg/25ml Intravenous Injection, Solution, Concentrate by Sanof-aventis U.S. LLC

Other drugs which contain Isatuximab-irfc or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 30 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA